| Theme | Dialysis Amyloidosis -- Present State of the Art | |
|---|---|---|
| Title | Drug treatment for dialysis amyloidosis | |
| Publish Date | 2004/02 | |
| Author | Kenji Arizono | Department of Nephrology, Kumamoto Central Hospital |
| Author | Hiroyoshi Fukui | Department of Nephrology, Kumamoto Central Hospital |
| [ Summary ] | Prevention is very important because drug treatment of dialysis amyloidosis is very difficult at the present time. We think it is important to reduce beta2-microglobulin and improve uremic states for prevention. Dialysis dose, the use of biocompatible membranes and ultrapure dialysis fluids play important roles in the treatment of dialysis amyloidosis. | |